- BioCryst compensation committee granted inducement equity awards to 12 newly hired employees effective April 1, 2026.
- Awards included stock options covering 33,950 shares at an exercise price of $9.38 per share.
- Grants also included restricted stock units covering 123,350 shares.
- Options and RSUs vest in four equal annual installments starting one year from grant date.
- Stock options carry a 10-year term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604030700PRIMZONEFULLFEED9683582) on April 03, 2026, and is solely responsible for the information contained therein.
Comments